Correction to: Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia–reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway
verfasst von:
Xiao-Qian Li, Feng-Shou Chen, Wen-Fei Tan, Bo Fang, Zai-Li Zhang, Hong Ma
The original version of the article [1] unfortunately contained a mistake. The error occurred in representative images of double immunofluorescence of Fig. 6.
Fig. 6
Effects of the miR-129-5p mimic and mimic control on HMGB1 expression in specific cell types of the spinal cord after IR. a Representative photomicrographs showing the localization of the fluorescence signals for HMGB1 in neurons and microglia at 48 h after IR. Arrows indicate co-localization. Scale bars = 50 μm. b Quantification of HMGB1 signals was performed based on the average of three independent images. c Quantification of HMGB1-positive neurons and microglia in the spinal cords at 48 h after IR. Data are expressed as the mean ± SD. *P < 0.05 versus the Sham group. #P < 0.05 versus the IR group
×
The other data and the conclusion in the publication are real and reliable.
Anzeige
It has been corrected in this correction.
The correct version of Fig. 6 is given in this Correction article.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Correction to: Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia–reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway
verfasst von
Xiao-Qian Li Feng-Shou Chen Wen-Fei Tan Bo Fang Zai-Li Zhang Hong Ma
Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.
Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.
Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.
Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.
